World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
64
Citations
18831
World Ranking
2902
National Ranking
192

Viktor Umansky publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Viktor Umansky sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 183 publications — 28th percentile

28% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Viktor Umansky D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Viktor Umansky sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 64 D-Index — 41st percentile

41% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Viktor Umansky is affiliated with Heidelberg University in Germany and works primarily in the fields of Immunology and Microbiology, Medicine, and Biochemistry, Genetics and Molecular Biology. Their research focuses on topics such as immune cells in cancer, cancer immunotherapy and biomarkers, immunotherapy and immune responses, immune cell function and interaction, immune response and inflammation, chemokine receptors and signaling, and histone deacetylase inhibitors research.

Their frequent coauthors include Jochen Utikal, Peter Altevogt, Christopher Groth, Ihor Arkhypov, and Daniel Novak. Viktor Umansky has published multiple articles in leading scientific journals, with recurrent contributions to the Journal for ImmunoTherapy of Cancer, International Journal of Molecular Sciences, Cancers, International Journal of Cancer, and Frontiers in Immunology.

Significant recent publications include the following:

  • IL-6 as a major regulator of MDSC activity and possible target for cancer immunotherapy, 2020, Cellular Immunology
  • Myeloid-derived suppressor cells in cancer and cancer therapy, 2024, Nature Reviews Clinical Oncology
  • IL-6 regulates CCR5 expression and immunosuppressive capacity of MDSC in murine melanoma, 2020, Journal for ImmunoTherapy of Cancer
  • Eosinophil accumulation predicts response to melanoma treatment with immune checkpoint inhibitors, 2020, OncoImmunology
  • STAT3 inhibitor Napabucasin abrogates MDSC immunosuppressive capacity and prolongs survival of melanoma-bearing mice, 2022, Journal for ImmunoTherapy of Cancer

The scientist's research extensively covers myeloid-derived suppressor cells (MDSC) and their role in cancer and cancer therapy, as well as the regulatory functions of IL-6 in immune responses related to cancer progression. Their work also encompasses studies on immune checkpoint inhibitors and molecular pathways that influence immune cell behavior in the tumor microenvironment.

Viktor Umansky's contributions mostly span immunology, oncology, and molecular biology subfields, highlighting the intersection of immune mechanisms and cancer biology. The body of work includes 42 publications in immunology, 22 in oncology, and 16 in molecular biology.

Best Publications

  • Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards

    Vincenzo Bronte;Sven Brandau;Shu Hsia Chen;Mario P. Colombo

  • NASH limits anti-tumour surveillance in immunotherapy-treated HCC

    Dominik Pfister;Dominik Pfister;Nicolás Gonzalo Núñez;Roser Pinyol;Olivier Govaere

  • Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progression

    Christopher Groth;Christopher Groth;Xiaoying Hu;Xiaoying Hu;Rebekka Weber;Rebekka Weber;Viktor Fleming;Viktor Fleming

  • Myeloid-Derived Suppressor Cells Hinder the Anti-Cancer Activity of Immune Checkpoint Inhibitors.

    Rebekka Weber;Rebekka Weber;Viktor Fleming;Viktor Fleming;Xiaoying Hu;Xiaoying Hu;Vasyl Nagibin;Vasyl Nagibin

  • Tumor-Infiltrating Monocytic Myeloid-Derived Suppressor Cells Mediate CCR5-Dependent Recruitment of Regulatory T Cells Favoring Tumor Growth

    Eva Schlecker;Ana Stojanovic;Christian Eisen;Christian Quack

  • The Role of Myeloid-Derived Suppressor Cells (MDSC) in Cancer Progression

    Viktor Umansky;Carolin Blattner;Christoffer Gebhardt;Jochen Utikal

  • Targeting Myeloid-Derived Suppressor Cells to Bypass Tumor-Induced Immunosuppression.

    Viktor Fleming;Viktor Fleming;Xiaoying Hu;Xiaoying Hu;Rebekka Weber;Rebekka Weber;Vasyl Nagibin;Vasyl Nagibin

  • Bone marrow as a priming site for T-cell responses to blood-borne antigen

    Markus Feuerer;Philipp Beckhove;Natalio Garbi;Yolanda Mahnke

  • NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo

    Tadepally Lakshmikanth;Shannon Burke;Talib Hassan Ali;Silvia Kimpfler

  • Chronic inflammation promotes myeloid-derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma model

    Meyer C;Sevko A;Ramacher M;Bazhin Av

  • Myeloid Cells and Related Chronic Inflammatory Factors as Novel Predictive Markers in Melanoma Treatment with Ipilimumab.

    Christoffer Gebhardt;Alexandra Sevko;Huanhuan Jiang;Huanhuan Jiang;Ramtin Lichtenberger

  • SOX2 in development and cancer biology.

    Daniel Novak;Laura Hüser;Jonathan J. Elton;Viktor Umansky

  • Myeloid-derived suppressor cells in cancer and cancer therapy

    Unknown

  • CTLA-4 and PD-L1 Checkpoint Blockade Enhances Oncolytic Measles Virus Therapy

    Christine E Engeland;Christine E Engeland;Christian Grossardt;Rūta Veinalde;Sascha Bossow

  • IL-6 as a major regulator of MDSC activity and possible target for cancer immunotherapy

    Rebekka Weber;Christopher Groth;Samantha Lasser;Ihor Arkhypov

  • Antitumor effect of paclitaxel is mediated by inhibition of myeloid-derived suppressor cells and chronic inflammation in the spontaneous melanoma model.

    Alexandra Sevko;Alexandra Sevko;Tillmann Michels;Tillmann Michels;Melissa Vrohlings;Melissa Vrohlings;Ludmila Umansky

  • Body fluid exosomes promote secretion of inflammatory cytokines in monocytic cells via Toll-like receptor signaling.

    Niko P. Bretz;Johannes Ridinger;Anne-Kathleen Rupp;Katharina Rimbach

  • Extracellular vesicle-mediated transfer of functional RNA in the tumor microenvironment

    Kirsten Ridder;Alexandra Sevko;Janina Heide;Maria Dams

  • Tumor-derived microRNAs induce myeloid suppressor cells and predict immunotherapy resistance in melanoma

    Veronica Huber;Viviana Vallacchi;Viktor Fleming;Xiaoying Hu

  • Deciphering myeloid-derived suppressor cells: isolation and markers in humans, mice and non-human primates

    Luca Cassetta;Espen Sønderaal Bækkevold;Sven Brandau;Anna Bujko

  • Low-dose gemcitabine depletes regulatory T cells and improves survival in the orthotopic Panc02 model of pancreatic cancer.

    Ivan Shevchenko;Svetlana Karakhanova;Sabine Soltek;Julia Link

Frequent Co-Authors

Jochen Utikal
Jochen Utikal German Cancer Research Center
Philipp Beckhove
Philipp Beckhove German Cancer Research Center
Dirk Schadendorf
Dirk Schadendorf University of Duisburg-Essen
Michael R. Shurin
Michael R. Shurin University of Pittsburgh
Volker Schirrmacher
Volker Schirrmacher German Cancer Research Center
Masashi Kato
Masashi Kato Nagoya University
Hellmut G. Augustin
Hellmut G. Augustin Heidelberg University
Jens Werner
Jens Werner Ludwig-Maximilians-Universität München
Christine S. Falk
Christine S. Falk Hannover Medical School
Peter Altevogt
Peter Altevogt German Cancer Research Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in immunology often intersects with advanced healthcare roles, particularly in nursing and specialized medical fields. For those looking to enhance their qualifications, exploring top pmhnp programs can be a strategic step. These programs not only offer strong clinical placement rates but also prepare nurses for critical roles in psychiatric mental health, a field closely related to immunological impacts on mental health conditions.

Cost is a crucial consideration for many students. Identifying the cheapest psych np programs online allows aspiring nurse practitioners to access quality education without excessive financial strain. Balancing affordability with program quality ensures a sound investment in one’s future career.

Salary expectations also influence career decisions. Understanding the doctorate in nursing salary by state helps candidates target regions where their advanced qualifications are rewarded with competitive compensation. This insight is valuable when planning where to practice after graduation.

For nurses interested in expanding their expertise, a specialized fnp to acnp bridge program online offers a pathway to acute care nursing. This transition supports career growth and broader clinical opportunities, making it an excellent option for those with foundational nursing credentials aiming to specialize further.

Best Scientists Citing Viktor Umansky

Trending Scientists

Recently Published Articles